Cargando…
MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding
MYC's role in promoting tumorigenesis is beyond doubt, but its function in the metastatic process is still controversial. Omomyc is a MYC dominant negative that has shown potent antitumor activity in multiple cancer cell lines and mouse models, regardless of their tissue of origin or driver mut...
Autores principales: | Massó-Vallés, Daniel, Beaulieu, Marie-Eve, Jauset, Toni, Giuntini, Fabio, Zacarías-Fluck, Mariano F., Foradada, Laia, Martínez-Martín, Sandra, Serrano, Erika, Martín-Fernández, Génesis, Casacuberta-Serra, Sílvia, Castillo Cano, Virginia, Kaur, Jastrinjan, López-Estévez, Sergio, Morcillo, Miguel Ángel, Alzrigat, Mohammad, Mahmoud, Loay, Luque-García, Antonio, Escorihuela, Marta, Guzman, Marta, Arribas, Joaquín, Serra, Violeta, Larsson, Lars-Gunnar, Whitfield, Jonathan R., Soucek, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973395/ https://www.ncbi.nlm.nih.gov/pubmed/36860495 http://dx.doi.org/10.1158/2767-9764.CRC-21-0103 |
Ejemplares similares
-
Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanoma
por: Zacarías-Fluck, Mariano F., et al.
Publicado: (2023) -
The Wnt signaling receptor Fzd9 is essential for Myc-driven tumorigenesis in pancreatic islets
por: Zacarías-Fluck, Mariano F, et al.
Publicado: (2021) -
BET inhibition is an effective approach against KRAS-driven PDAC and NSCLC
por: Jauset, Toni, et al.
Publicado: (2018) -
Pharmacokinetic Analysis of Omomyc Shows Lasting Structural Integrity and Long Terminal Half-Life in Tumor Tissue
por: Beaulieu, Marie-Eve, et al.
Publicado: (2023) -
Ibrutinib repurposing: from B-cell malignancies to solid tumors
por: Massó-Vallés, Daniel, et al.
Publicado: (2016)